Mr. Trideep Saikia | Pharmaceutics | Best Researcher Award

Assistant Professor at Girijananda Chowdhury University, India

Mr. Trideep Saikia is a dynamic pharmaceutical researcher and academic with a strong foundation in scientific writing, advanced drug delivery systems, and preclinical pharmacological studies. His work spans diabetes and cancer research, with significant contributions in nanoformulation, dry powder inhalers, and targeted therapy using animal models. Currently serving as an Assistant Professor at Girijananda Chowdhury University, he combines academic leadership with cutting-edge research and scientific publication. Mr. Saikia is also an active peer reviewer and patent contributor, with a growing global impact in pharmaceutical sciences.

Publication Profile

Scopus

Google Scholar

Educational Background

Ph.D. in Pharmaceutical Sciences (Ongoing) – Dibrugarh University
MBA in Marketing Management (Ongoing) – Mizoram University
M.Pharm in Pharmaceutics – Mizoram University, 2020 (86.2%)
B.Pharm – Assam Science and Technology University, 2017 (78.6%)
PG Diploma in Computer Applications – IITA, Guwahati, 2013 (Grade A)

Professional Experience

1. Assistant Professor
Girijananda Chowdhury University, Guwahati
Jan 2021 – Present

Led lectures in pharmaceutics and mentored student researchers
Authored 18+ peer-reviewed publications
Operated key analytical instruments (HPLC, SEM, DSC)

2. Junior Research Fellow
Assam Down Town University & NIPER-Guwahati
Aug 2020 – Jan 2021

Preclinical studies on diabetes using rat models
Manuscript writing and data visualization

3. Research Trainee
CSIR-NEIST
Jul 2019 – Jun 2020

In vitro cancer research, analytical techniques, and cell culture studies

4. Medical Representative
Novartis India Ltd.
Aug 2017 – Aug 2018

Promoted pharmaceutical products and conducted market analysis

Research Interests

Preclinical Drug Evaluation (Diabetes, Cancer)
Advanced Drug Delivery Systems: Nanoformulations, Dry Powder Inhalers
In vitro and In vivo Pharmacological Testing
Pharmacokinetics and Pharmacodynamics
Scientific Communication and Research Writing

Awards and Honors

Peer Reviewer for high-impact journals under Dove Medical Press, including:
- International Journal of Nanomedicine (IF 7.5)
- Journal of Inflammation Research (IF 4.6)
- Cancer Management and Research (IF 2.5)
Granted German Patent: Novel multiepitope vaccine design
Indian Patent Published: Surgical Stiletto for maxillary dissection in Danio rerio
Poster Presentations:
- ESTEC-2020 (CSIR-NEIST, Jorhat)
- 68th Indian Pharmaceutical Congress, Visakhapatnam
- North East Pharmaceutical Convention-2017, Guwahati

Conclusion

Mr. Trideep Saikia exemplifies a strong blend of academic excellence, innovative pharmaceutical research, and scientific communication expertise. With substantial experience in drug delivery systems, a growing list of publications, and a commendable involvement in peer review and patent innovation, he stands out as a promising contributor to pharmaceutical and biomedical research. Continued focus on clinical translation and international collaboration will further enhance his impact.

Publications

Development of Dry Powder Inhaler formulation for site specific delivery of nanoconjugates loaded with Curcumin and BCL2 siRNA in Lung Cancer
M. Lahan, T. Saikia, R. Baishya, A. Bharali, S. Baruah, S. Ghosh, N. Biswas, …
Pulmonary Pharmacology & Therapeutics | 2025 | 102361 | In press

QBD based and Box-Behnken Design based PLGA Nanoparticles for Sustained Release of Curcumin (Cur-PLGA-NS) In A549 Lung Cancer Cells
M. Lahan, S.K. Sarma, T. Saikia, K. Dutta, R. Baishya, A. Bharali, J. Nath, …
Journal of Chemical Health Risks | 2025 | 15(3), 1140–1450 | In press

Lipid-drug conjugates for cancer chemotherapy
T. Saikia, B.P. Sahu, M.K. Das
Lipid-Drug Conjugates | 2025 | 191–219 | In press

Multifunctional approach with LHRH-mediated PLGA nanoconjugate for site-specific codelivery of curcumin and BCL2 siRNA in mice lung cancer
M. Lahan, T. Saikia, K. Dutta, R. Baishya, A. Bharali, S. Baruah, R. Bharadwaj, …
Future Journal of Pharmaceutical Sciences | 2024 | 10(1), 163 | 2 citations

Citrus aurantifolia-derived carbon quantum dots with red fluorescence emission for codelivery with curcumin as theranostic liposomes for lung cancer
A. Sonowal, A. Bharali, T. Saikia, S. Kushari, M. Lahon, J.M. Kalita, N. Biswas, …
Future Journal of Pharmaceutical Sciences | 2024 | 10(1), 116 | 1 citation

Enhanced Lung Cancer Therapy via Co-Encapsulation of Docetaxel and Betulinic Acid
T. Saikia, P. Rajak, B.P. Sahu, L. Patowary
Drugs and Drug Candidates | 2024 | 3(3), 566–597 | 2 citations

Development of paclitaxel proliposomal dry powder inhaler (PTX-PLM-DPI) by freeze-drying method for lung cancer
C. Borah, T. Saikia, A. Bharali, M. Lahan, N. Biswas, B.P. Sahu
Drugs and Drug Candidates | 2024 | 3(1), 275–290 | 3 citations

Mechanistic Aspects of Neurodegeneration in Alzheimer’s Disease and the Role of Phytochemicals
T. Saikia, T. Kalita, B.P. Sahu, P. Rajak, B. Deka, A. Bharali
Computational and Experimental Studies in Alzheimer’s Disease | 2024 | 91–121 | In press

3-D models for studying microplastics effects on humans
Y. Aryanfar, Y.S. Wu, J.L.G. Alcaraz, R.P.I. Vidal, A.I. Osman, A.S.A. Manap, T. Saikia, …
Microplastics in Agriculture and Food Science | 2025 | 417–441 | In press

Bioconversion of organic waste by insects – A comprehensive review
S.A. Siddiqui, I.A. Harahap, J. Osei-Owusu, T. Saikia, Y.S. Wu, I. Fernando, …
Process Safety and Environmental Protection | 2024 | 25 citations

Production and growth of microalgae in urine and wastewater: A review
S.A. Siddiqui, Y.S. Wu, T. Saikia, İ. Ucak, M. Afreen, M.A. Shah, R.D. Ayivi
Environmental Chemistry Letters | 2023 | 21(5), 2789–2823 | 2 citations

Microplastic sources, formation, toxicity and remediation: a review
A.I. Osman, M. Hosny, A.S. Eltaweil, S. Omar, A.M. Elgarahy, M. Farghali, T. Saikia, …
Environmental Chemistry Letters | 2023 | 21(4), 2129–2169 | 469 citations

Trideep Saikia | Pharmaceutics | Best Researcher Award